News

Fiona Havers, who oversaw CDC respiratory virus data, told colleagues she no longer had confidence the data would be used ...
Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
A scientist in charge of Covid-19 and respiratory syncytial virus data has abruptly resigned, telling colleagues she doesn’t ...
A second senior CDC official has resigned in two weeks, citing fears that scientific integrity is being undermined under ...
A Centers for Disease Control and Prevention official who led the agency's network to study hospitalization trends from ...
A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in US infants.
I am delighted that your husband has barreled into fatherhood like an avenging angel. I think that you should sit him down ...
WHO also reported that global COVID-19 deaths keep declining. The VDH is no longer reporting COVID fatalities and cases in ...
Aldeyra has resubmitted its new drug application for reproxalap, an investigational dry eye treatment, which contained new ...